Lei Deng, MD, discusses how precision medicine, immunotherapy and rapid molecular testing are improving outcomes for patients ...
Gilead has struck a deal to buy Germany-based Tubulis for $3.15 billion upfront and up to $1.85 billion in milestones, securing an antibody-drug conjugate (ADC) candidate that is racing toward pivotal ...
Newly uncloaked Stipple Bio is connecting the dots toward multiple early-stage clinical studies for its lead precision ...
The integration supports treatment decisions across cancer care stages and helps reduce administrative tasks for clinicians.
Nearly 400 trials and Belgium’s isotope hub signal rapid clinical diversification for radioligand therapy — but policy, ...
Gilead Sciences, Inc. (Nasdaq: GILD) today announced it has entered into a definitive agreement to acquire Tubulis GmbH, a private Germany-based, clinical-stage biotechnology company developing ...
The care that older adults with advanced cancer receive often does not align with their preferences and values, study ...
Rising cancer prevalence, demand for precise dosage, expanding tele-oncology networks AI Tele-Oncology Radiation Dose ...
A new article in the News and Perspectives section of the Journal of Medical Internet Research showcases the transformative ...
Delivering value-based oncology care requires both scientific breakthroughs and deliberate system redesign, experts concurred during this February IVBM in Los Angeles. Across expert panels spanning ...
Oncology M&A activity is accelerating as large pharmaceutical companies race to replenish pipelines facing patent cliffs and ...
On Oncology Nursing Day, we recognize and celebrate the dedication, compassion and expertise of oncology nurses across the MUHC. Every day, these professionals provide exceptional clinical care while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results